Liver Cancer
Liver cancer, specifically hepatocellular carcinoma (HCC), is a type of cancer that originates in the liver cells. It can cause symptoms like weight loss, abdominal pain, and jaundice.
Hepatocellular Cancer and Lung Cancer: ABBV-324 vs. Lenvatinib
We are comparing an intravenous treatment to an oral medication for adults with hepatocellular cancer or squamous-cell lung cancer. The study aims to assess side effects and changes in disease activity.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes, including squamous-cell carcinoma. Symptoms may include a persistent cough, chest pain, and difficulty breathing.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Hm Sanchinarro
Oncología
Chamartín, Spain
Hospital Universitario Fundacion Jimenez Diaz
Oncología
Madrid, Spain
Sponsor: AbbVie Deutschland GmbH & Co. KG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.